These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11131647)

  • 1. Cellular predictive factors for the drug response of lung cancer.
    Volm M; Rittgen W
    Anticancer Res; 2000; 20(5B):3449-58. PubMed ID: 11131647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
    Volm M; Koomägi R
    Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interrelationships between microvessel density, expression of VEGF and resistance to doxorubicin of non-small lung cell carcinoma.
    Volm M; Koomägi R; Mattern J
    Anticancer Res; 1996; 16(1):213-7. PubMed ID: 8615611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression profile of proteins involved in the xenotransplantability of non-small cell lung cancers into athymic nude mice.
    Efferth T; Koomägi R; Mattern J; Volm M
    Int J Oncol; 2002 Feb; 20(2):391-5. PubMed ID: 11788907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The implications of proliferation and apoptosis for lung cancer metastasis.
    Volm M; Koomagi R
    Oncol Rep; 1999; 6(2):373-6. PubMed ID: 10023008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor, p53, Rb, Bcl-2 expression and response to chemotherapy in advanced non-small cell lung cancer.
    Ludovini V; Gregorc V; Pistola L; Mihaylova Z; Floriani I; Darwish S; Stracci F; Tofanetti FR; Ferraldeschi M; Di Carlo L; Ragusa M; Daddi G; Tonato M
    Lung Cancer; 2004 Oct; 46(1):77-85. PubMed ID: 15364135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P-glycoprotein associated expression of c-fos and c-jun products in human lung carcinomas.
    Volm M
    Anticancer Res; 1993; 13(2):375-8. PubMed ID: 8100127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associated expression of protein kinase C with resistance to doxorubicin in human lung cancer.
    Volm M; Pommerenke EW
    Anticancer Res; 1995; 15(2):463-6. PubMed ID: 7763022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer.
    Volm M; Koomägi R
    Anticancer Res; 2000; 20(3A):1527-33. PubMed ID: 10928066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Turley H; Talks K; Pezzella F; Gatter KC; Harris AL
    Br J Cancer; 2001 Sep; 85(6):881-90. PubMed ID: 11556841
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells.
    Hsu YL; Kuo PL; Lin CC
    Life Sci; 2004 Jul; 75(10):1231-42. PubMed ID: 15219811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation analysis among expression of ERCC-1, metallothionein, p53 and platinum resistance and prognosis in advanced non-small cell lung cancer].
    Huang PY; Liang XM; Lin SX; Luo RZ; Hou JH; Zhang L
    Ai Zheng; 2004 Jul; 23(7):845-50. PubMed ID: 15248926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2F1 overexpression correlates with thymidylate synthase and survivin gene expressions and tumor proliferation in non small-cell lung cancer.
    Huang CL; Liu D; Nakano J; Yokomise H; Ueno M; Kadota K; Wada H
    Clin Cancer Res; 2007 Dec; 13(23):6938-46. PubMed ID: 18056168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vascular thickness and cytostatic-resistant bronchial carcinoma].
    Volm M; Koomägi R; van Kaick G; Mattern J
    Dtsch Med Wochenschr; 1996 Mar; 121(10):291-4. PubMed ID: 8681711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
    Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
    Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profile of genes in non-small cell lung carcinomas from long-term surviving patients.
    Volm M; Koomägi R; Mattern J; Efferth T
    Clin Cancer Res; 2002 Jun; 8(6):1843-8. PubMed ID: 12060626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer.
    Shou Y; Hirano T; Gong Y; Kato Y; Yoshida K; Ohira T; Ikeda N; Konaka C; Ebihara Y; Zhao F; Kato H
    Br J Cancer; 2001 Nov; 85(11):1706-12. PubMed ID: 11742492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancer.
    Tas F; Duranyildiz D; Oguz H; Camlica H; Yasasever V; Topuz E
    Cancer Invest; 2006 Oct; 24(6):576-80. PubMed ID: 16982461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells.
    Ikuta K; Takemura K; Kihara M; Naito S; Lee E; Shimizu E; Yamauchi A
    Oncol Rep; 2005 Jun; 13(6):1229-34. PubMed ID: 15870947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis.
    Wang J; Liu X; Jiang W; Liang L
    Chin Med J (Engl); 2000 Nov; 113(11):985-90. PubMed ID: 11776132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.